Literature DB >> 9737670

A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli.

K Nagaraju1, N Raben, G Merritt, L Loeffler, K Kirk, P Plotz.   

Abstract

Muscle is an attractive target for gene therapy and for immunization with DNA vaccines and is also the target of immunological injury in myositis. It is important therefore to understand the immunologic capabilities of muscle cells themselves. In this study, we show that proinflammatory stimuli induce the expression of other cytokines such as IL-6, transforming growth factor-beta (TGF-beta), and granulocyte-macrophage colony-stimulating factor (GM-CSF) by muscle cells themselves, as well as the up-regulation of human leucocyte antigen (HLA) class I, class II and intercellular adhesion molecule-1 (ICAM-1). Thus, muscle cells have an inherent ability to express and respond to a variety of cytokines and chemokines. The levels of HLA class I, class II and ICAM-1 in inflamed muscle may be affected by the secreted products of the stimulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737670      PMCID: PMC1905062          DOI: 10.1046/j.1365-2249.1998.00664.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Induction of HLA-DR expression on human myoblasts with interferon-gamma.

Authors:  R Hohlfeld; A G Engel
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

2.  Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes.

Authors:  J J Kim; M L Bagarazzi; N Trivedi; Y Hu; K Kazahaya; D M Wilson; R Ciccarelli; M A Chattergoon; K Dang; S Mahalingam; A A Chalian; M G Agadjanyan; J D Boyer; B Wang; D B Weiner
Journal:  Nat Biotechnol       Date:  1997-07       Impact factor: 54.908

Review 3.  Animal models of myositis.

Authors:  P H Plotz; F W Miller
Journal:  Mt Sinai J Med       Date:  1988-11

4.  Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies.

Authors:  A G Engel; K Arahata
Journal:  Hum Pathol       Date:  1986-07       Impact factor: 3.466

Review 5.  Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

Authors:  A B Roberts; M B Sporn
Journal:  Growth Factors       Date:  1993       Impact factor: 2.511

6.  Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product.

Authors:  D Figarella-Branger; J F Pellissier; N Bianco; B Devictor; M Toga
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin.

Authors:  T Kitamura; T Tange; T Terasawa; S Chiba; T Kuwaki; K Miyagawa; Y F Piao; K Miyazono; A Urabe; F Takaku
Journal:  J Cell Physiol       Date:  1989-08       Impact factor: 6.384

8.  Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-gamma.

Authors:  R Mantegazza; S M Hughes; D Mitchell; M Travis; H M Blau; L Steinman
Journal:  Neurology       Date:  1991-07       Impact factor: 9.910

9.  Expression and function of heterotypic adhesion molecules during differentiation of human skeletal muscle in culture.

Authors:  J R Beauchamp; D J Abraham; G Bou-Gharios; T A Partridge; I Olsen
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

10.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

Authors:  M M Shull; I Ormsby; A B Kier; S Pawlowski; R J Diebold; M Yin; R Allen; C Sidman; G Proetzel; D Calvin
Journal:  Nature       Date:  1992-10-22       Impact factor: 49.962

View more
  46 in total

1.  Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies.

Authors:  K Nagaraju; N Raben; L Loeffler; T Parker; P J Rochon; E Lee; C Danning; R Wada; C Thompson; G Bahtiyar; J Craft; R Hooft Van Huijsduijnen; P Plotz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  Short-Wave Diathermy Pretreatment and Inflammatory Myokine Response After High-Intensity Eccentric Exercise.

Authors:  John P Vardiman; Nicole Moodie; Jacob A Siedlik; Rebecca A Kudrna; Zachary Graham; Philip Gallagher
Journal:  J Athl Train       Date:  2015-04-06       Impact factor: 2.860

3.  Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand.

Authors:  Peter Szodoray; Philip Alex; Nicholas Knowlton; Michael Centola; Igor Dozmorov; Istvan Csipo; Annamaria T Nagy; Tamas Constantin; Andrea Ponyi; Britt Nakken; Katalin Danko
Journal:  Rheumatology (Oxford)       Date:  2010-06-29       Impact factor: 7.580

4.  Lipoic Acid Exerts Antioxidant and Anti-inflammatory Effects in Response to Heat Shock in C2C12 Myotubes.

Authors:  Cheng-Tse Lee; Li-Ching Chang; Pei-Fung Wu
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

5.  CC family chemokines directly regulate myoblast responses to skeletal muscle injury.

Authors:  Linda Yahiaoui; Dusanka Gvozdic; Gawiyou Danialou; Matthias Mack; Basil J Petrof
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

6.  Effects of rosiglitazone on inflammation in Otsuka long-evans Tokushima Fatty rats.

Authors:  Jin Woo Lee; Il Seong Nam-Goong; Jae Geun Kim; Chang Ho Yun; Se Jin Kim; Jung Il Choi; Young Il Kim; Eun Sook Kim
Journal:  Korean Diabetes J       Date:  2010-06-30

7.  Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis.

Authors:  Charles Kwok-chong Li; Paul Knopp; Halima Moncrieffe; Bhanu Singh; Sonia Shah; Kanneboyina Nagaraju; Hemlata Varsani; Bin Gao; Lucy R Wedderburn
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

Review 8.  Dermatomyositis, complicated with pneumomediastinum, successfully treated with cyclosporine A: a case report and review of literature.

Authors:  Hui-Jung Kim; Yun-Kyung Hong; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2008-12-18       Impact factor: 2.631

9.  The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis.

Authors:  Liguo Yin; Yongpeng Ge; Hanbo Yang; Qinglin Peng; Xin Lu; Yamei Zhang; Guochun Wang
Journal:  Clin Rheumatol       Date:  2016-08-08       Impact factor: 2.980

Review 10.  Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects.

Authors:  Bente Klarlund Pedersen; Adam Steensberg; Pernille Keller; Charlotte Keller; Christian Fischer; Natalie Hiscock; Gerrit van Hall; Peter Plomgaard; Mark A Febbraio
Journal:  Pflugers Arch       Date:  2003-02-18       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.